Biobanking 3.0: evidence based and customer focused biobanking

Area of Science:

• Biobanking and Biomedical Research Infrastructure

Background:

• Biobanking has evolved through stages focusing on specimen/data quantity (1.0) and quality (2.0).
• These earlier stages primarily involved internal operational development within biobanks.
• A need exists to ensure long-term financial sustainability for biobank infrastructures.

Purpose of the Study:

• Introduce the concept of Biobanking 3.0.
• Shift focus to external stakeholder value and impact.
• Establish a path toward balanced investment and sustainability in biobanking.

Main Methods:

• Define Biobanking 3.0 as an evolution of previous stages.
• Emphasize enhancing value for patients, funders, and research customers.
• Focus on improving understanding and perception of biobank value.

Main Results:

• Biobanking 3.0 enhances value perception for patients, funders, and researchers.
• Patients and donors gain insight into biospecimen and data utilization.
• Funders benefit from planned investment and impact monitoring.

Conclusions:

• Biobanking 3.0 promotes social, operational, and financial sustainability.
• Adoption improves acceptability, efficiency, and accomplishment in biobanking.
• This stakeholder-centric model is crucial for the future of biobanking infrastructure.